Impact of hepatitis C virus infection in renal allograft recipients.
Yacheng
Y
Y
Kidney Transplantation Center, Department of Urology, Changzheng Hospital, Shanghai, People's Republic of China.
Zhilian
M
M
Yeuhua
Z
Z
D000328:Adult; D002681:China; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival; D006526:Hepatitis C / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology*; D018937:Hepatitis C Antibodies / Q000097:blood; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D011183:Postoperative Complications / Q000821:virology; D015995:Prevalence; D012367:RNA, Viral / Q000097:blood; D012189:Retrospective Studies; D014184:Transplantation, Homologous
D018937:Hepatitis C Antibodies; D007166:Immunosuppressive Agents; D012367:RNA, Viral